The context provided doesn't list specific "new" biologics by their release date or discovery. However, it mentions several biologics used in the treatment of rheumatoid arthritis (RA), including:
- **Tumor Necrosis Factor (TNF) Alpha Inhibitors**: Cimzia (certolizumab pegol), Enbrel (etanercept), Humira (adalimumab), and Show Full Answer
The context provided doesn't list specific "new" biologics by their release date or discovery. However, it mentions several biologics used in the treatment of rheumatoid arthritis (RA), including:
- **Tumor Necrosis Factor (TNF) Alpha Inhibitors**: Cimzia (certolizumab pegol), Enbrel (etanercept), Humira (adalimumab), and Remicade (infliximab).
- **B-Cell Inhibitors**: Rituxan (rituximab).
- **Interleukin (IL) Inhibitors**: Actemra (tocilizumab) and Kineret (anakinra).
- **Selective Costimulation Modulators**: Orencia (abatacept).
These biologics are not necessarily new to the market but are part of the current treatment landscape for RA. For the latest biologics or any newly approved treatments, consulting a healthcare professional or recent medical literature would provide the most up-to-date information.
February 19, 2024